DJIA 17,072.54 -7.03 -0.04%
NASDAQ 4,574.01 16.31 0.36%
S&P 500 2,000.45 3.71 0.19%
market minute promo

Gilead Sciences (NASDAQ: GILD)

107.25 -0.26 (-0.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $107.25 -0.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $107.90
Previous Close $107.51
Daily Range $106.78 - $108.24
52-Week Range $58.81 - $108.77
Market Cap $162.1B
P/E Ratio 24.21
Dividend (Yield) $0.00 (0.0%)
Volume 7,535,181
Average Daily Volume 13,501,126
Current FY EPS $7.26

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape

Why Gilead Sciences (GILD) Could Be Positioned for a Surge? - Tale of the Tape

Why Gilead Sciences (GILD) Could Be Positioned for a Surge? - Tale of the Tape

Market Posts Best August In 14 Years. Why Don't Investors Feel Better?

Today's Market: Red Hot Biotech And Big Pharma Names To Watch

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog

RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog

RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog

Guggenheim S&P 500 Equal Weight ETF Experiences Big Inflow

When Will M&A Come To The Hepatitis C Space?

Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences

European approval of Bristol-Myers Squibb's Daklinza could derail sales of Johnson & Johnson's Olysio, but is unlikely to unseat Gilead's Sovaldi.

See More GILD News...

GILD's Top Competitors

GILD $107.25 (-0.24%)
Current stock: GILD
AMGN $138.81 (0.09%)
Current stock: AMGN
CELG $94.77 (0.07%)
Current stock: CELG
$0.00 (0.00%)
Current stock: